ArticleQuantitative imaging in medicine and surgery2025
Radiation burden from recurrent computed tomography examinations in patients treated with immunotherapy for malignant melanoma.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Computed tomography (CT) examination is among the imaging modalities burdened with a relatively high dose of ionizing radiation. Nowadays, CT is an integral part of modern medicine. In the field of oncology care, patients undergo repeated CT examinations for initial diagnosis, staging, and follow-up. However, we usually only have a rough idea of how high the radiation exposure these examinations actually represent for the patient. It is general agreement that received effective dose (ED) greater than 100 mSv represents a significantly higher risk of radiation-induced fatal malignancy over the course of the patient's life. In our study, we focused on the radiation burden that these recurrent CT scans represent for patients undergoing immunotherapy for metastatic malignant melanoma. Methods: Our study had a retrospective design. Study group consisted of all patients treated with immunotherapy for metastatic malignant melanoma between 2016 and 2021. We included 54 patients with median age of 66 years, interquartile range (IQR) 15 years. We retrospectively calculated the EDs of their individual CT examinations (n=622) then calculated the cumulative dose (CED) for each patient. Results: Study subjects underwent median 8 CT examinations (IQR, 9 examinations), with a minimum 2 and a maximum 25 CT examinations. In 35 patients (64%) CED exceeded 100 mSv, in 17 (31%) subjects CED was over 200 mSv and in 11 (20%) was over 300 mSv. The highest achieved CED was 547.7 mSv. Conclusions: We proved that recurrent CT scans performed for follow-up care are associated with a high CED. A CED higher than 100 mSv, is considered as significant for the risk of developing radiation-induced malignancy later in the patient's life. Although other factors such as age, gender or individual sensitivity must be taken into account, the high CED from such examinations should be considered, especially when creating follow-up care plans and recommendations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.